Cargando…

STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death

BACKGROUND: In an effort to achieve better cancer therapies, we elucidated the combination cancer therapy of STI571 (an inhibitor of Bcr-Abl and clinically used for chronic myelogenous leukemia) and TNF-related apoptosis-inducing ligand (TRAIL, a developing antitumor agent) in leukemia, colon, and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Duen-Yi, Chao, Yee, Tai, Ming-Hui, Yu, Yang-Hao, Lin, Wan-Wan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348077/ https://www.ncbi.nlm.nih.gov/pubmed/22462553 http://dx.doi.org/10.1186/1423-0127-19-35

Ejemplares similares

Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation
por: Deutsch, E, et al.
Publicado: (2004)

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
por: Liu, W M, et al.
Publicado: (2002)

Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease
por: Re, D, et al.
Publicado: (2002)

A combination of STI571 and BCR-ABL1 siRNA with overexpressed p15INK4B induced enhanced proliferation inhibition and apoptosis in chronic myeloid leukemia
por: Xia, D.Y., et al.
Publicado: (2014)

Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro
por: Zhang, Peilin, et al.
Publicado: (2003)

Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2012)

Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles
por: Lin, You-Zhe, et al.
Publicado: (2021)

Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells
por: Ke, Rong, et al.
Publicado: (2018)

Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death
por: Semba, Manami, et al.
Publicado: (2022)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

Management of Skin Toxicity Related to the Use of Imatinib Mesylate (STI571, Glivec™) for Advanced Stage Gastrointestinal Stromal Tumours
por: Scott, Lucy C., et al.
Publicado: (2005)

Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome‐wide cDNA Microarray Analysis
por: Kaneta, Yasuyuki, et al.
Publicado: (2002)

H-Ras regulation of TRAIL death receptor mediated apoptosis
por: Chen, Jun-Jie, et al.
Publicado: (2014)

Cell death leaves a new TRAIL
por: Overholtzer, Michael
Publicado: (2021)

TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors
por: Yang, Xi, et al.
Publicado: (2017)

Niacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation
por: Kim, Sung-Wook, et al.
Publicado: (2015)

Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL Sensitivity of Colon Cancer Cells
por: Setroikromo, Rita, et al.
Publicado: (2020)

Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells
por: Shlyakhtina, Yelyzaveta, et al.
Publicado: (2017)

Following the fat trail to death
por: Williams, Ruth
Publicado: (2009)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Andrographolide sensitizes human renal carcinoma cells to TRAIL-induced apoptosis through upregulation of death receptor 4
por: Bi, Ran, et al.
Publicado: (2020)

Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571)
por: Pinder, Elizabeth M., et al.
Publicado: (2007)

Expression of TNF-related apoptosis-inducing ligand (TRAIL) in keratinocytes mediates apoptotic cell death in allogenic T cells
por: Reimers, Kerstin, et al.
Publicado: (2009)

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death
por: Chen, Xin, et al.
Publicado: (2014)

IFN-β sensitizes TRAIL-induced apoptosis by upregulation of death receptor 5 in malignant glioma cells
por: Yoshimura, Sodai, et al.
Publicado: (2019)

Therapeutic targeting of TRAIL death receptors
por: Di Cristofano, Francesca, et al.
Publicado: (2023)

Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide
por: Weyhenmeyer, Birgit C., et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Induces Apoptosis as a TRAIL Sensitizer via Activation of Caspase 8 and Death Receptor 5 in Human Colon Cancer Cells
por: Kwon, Oh Sung, et al.
Publicado: (2020)

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019)

Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies
por: Favaro, Francesca, et al.
Publicado: (2023)

Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL
por: Ito, Tomohisa, et al.
Publicado: (2018)

Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors
por: Iurlaro, Raffaella, et al.
Publicado: (2017)

Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
por: Bertsch, U, et al.
Publicado: (2014)

Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells
por: Tiptiri-Kourpeti, Angeliki, et al.
Publicado: (2016)

Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells
por: Plissonnier, Marie-Laure, et al.
Publicado: (2017)

NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells
por: Ruggeri, P, et al.
Publicado: (2016)

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
por: Dufour, Florent, et al.
Publicado: (2017)

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors
por: Lee, Won Hyeok, et al.
Publicado: (2020)

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia
por: O'Brien, S G, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_msfk32c3q7mpidukfejhbmshp7